David Y. Takeda
National Cancer Institute(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, PARP inhibition in cancer therapy, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles(2017)3,590 cited
- → Mutational processes shape the landscape of TP53 mutations in human cancer(2018)575 cited
- → The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis(2015)478 cited
- → A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer(2018)331 cited
- → Prostate cancer reactivates developmental epigenomic programs during metastatic progression(2020)280 cited
- → DNA replication and progression through S phase(2005)193 cited
- → Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer(2021)162 cited
- → Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis(2018)136 cited
- → A Bipartite Substrate Recognition Motif for Cyclin-dependent Kinases(2001)130 cited
- → Degradation of Cdt1 during S Phase Is Skp2-independent and Is Required for Efficient Progression of Mammalian Cells through S Phase(2005)118 cited